Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian stock markets remain lackluster
Tue, 24 Sep 01:30 pm

The Indian stock markets are trading above the dotted line during the post noon trading session. Most of the sectoral indices are trading in green, with consumer durables and capital goods being the top gainers. However, stocks from IT and metal space are witnessing maximum selling pressure.

BSE-Sensex is up by 54 points and NSE-Nifty is trading up by 19 points. While BSE Mid Cap is trading up by 0.17%, BSE Mid Cap index is trading up by 0.11%. The rupee is trading at 62.54 to the US dollar.

Indian pharma stocks are trading mixed. JB chemicals and Ipca laboratories are among the top gainers, while Panacea biotech and Orchid chemicals are the leading losers. Lupin Ltd has announced that the company has entered into agreement with US based Onset dermatologics LLC (Onset). As per the agreement, Lupin will co-promote Onset's brand Locoid lotion (hydrocortisone butyrate 0.1%) in the US market. The company has given exclusive marketing rights to Lupin. The said drug is prescribed for mid potency steroid. Lupin will promote Locoid lotion to the US pediatricians, for the patients of age three months or more. Locoid Lotion is a corticosteroid indicated for the topical treatment of mild to moderate Atopic Dermatitis in patients 3 months of age and older. Atopic Dermatitis (AD) is one of the most common skin disorders in young children and has a prevalence of 10% to 20% in the first decade of life. This agreement will add one more drug to Lupin's branded portfolio. Lupin's branded portfolio comprises of brands like Suprax and Antara. Lupin was trading up by 0.19% at the time of writing.

Energy stocks are trading mixed with Chennai Petroleum and Gas Authority of India Ltd (GAIL) being the major gainers and Bharat Petroleum Corporation Ltd (BPCL) and Jindal Drill being the principal losers. A survey conducted by Nielsen has raised doubts over the government's claim of petrol being a rich man's fuel to discontinue the subsidy. The survey conducted by Nielsen for oil ministry's think tank 'Petroleum Planning & Analysis Cell' shows that two-wheelers are the largest consuming segment, guzzling 62% of total petrol. On the other hand, cars and three-wheelers account for 27% and 6% shares of petrol consumption respectively. The petrol consumption in the country has been pegged at 16 m tonnes. The consumption of diesel, that still enjoys government subsidy, is estimated at 69 m tonnes. Commercial vehicles and cars & sports utility vehicles are the large consumers accounting for respective shares of 38% and 19% in overall diesel consumption. Reportedly, the survey is part of the oil ministry's efforts in deciding the future course of action for managing the domestic oil market. Reportedly, oil imports increased by 9.5% to Rs 3,474.3 bn during the period April-August 2013 with subsidy estimates burgeoning to Rs 1,800 bn. The oil ministry is launching a fuel conservation campaign to limit rising demand.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Indian stock markets remain lackluster". Click here!

  

Related Views on News

LUPIN 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY21); Net Profit Down 64.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, LUPIN has posted a net profit of Rs 1 bn (down 64.2% YoY). Sales on the other hand came in at Rs 35 bn (down 20.2% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

How Much Money For Day Trading? (Fast Profits Daily)

Feb 22, 2021

In this video, I'll show you how to allocate your capital as a day trader.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Mar 5, 2021 10:02 AM

S&P BSE HEALTHCARE 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS